Guardant Health, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2022
For the year, the company expects Revenue of between $447 million and $450 million, an increase of 20%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.83 USD | +7.26% | +22.35% | +25.06% |
12/07 | GoodRx Holdings, Inc. Announces the Election of Ian T. Clark to its Board of Directors | CI |
28/06 | Top Premarket Gainers | MT |
1st Jan change | Capi. | |
---|---|---|
+25.06% | 385.95Cr | |
-32.86% | 868.21Cr | |
+15.74% | 242.89Cr | |
-26.46% | 183.93Cr | |
-7.09% | 172.7Cr | |
+40.61% | 116.36Cr | |
+54.75% | 84Cr | |
-9.17% | 70Cr | |
-9.18% | 59Cr | |
-19.58% | 24Cr |